Stockreport

Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease [Yahoo! Finance]

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report
PDF Topline Phase 3 results expected in 2H 2026 FOSTER CITY, Calif., January 26, 2026 BUSINESS WIRE )--Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a leading rare disease [Read more]